Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Livestrong Takes Hit after Armstrong Confession

By Pharmaceutical Processing | September 12, 2014

AUSTIN, Texas (AP) — The Livestrong cancer charity is reporting a sharp drop in donations and revenue after founder Lance Armstrong admitted taking performance-enhancing drugs during most of his record-setting cycling career.

In federal forms released this week, Livestrong noted its 2013 donations dipped 34 percent, from nearly $23 million to $15 million after Armstrong’s televised admission to Oprah Winfrey in January 2013. Total revenue also took a 38 percent dive after commercial sponsorships were canceled or not renewed.

Without specifically referring to Armstrong, Livestrong blamed the financial downturn on fallout from “revelations and disclosures” made in January 2013.

Armstrong, a cancer survivor, started the charity as the Lance Armstrong Foundation in 1997. He was removed from its board of directors in late 2012, around the same time the foundation changed its name.

A Livestrong spokeswoman did not immediately return a telephone message seeking comment. Livestrong President Doug Ulman thanked supporters in a letter titled “Never Give Up” and posted online Wednesday.

“Because of your support, you helped us weather a tough period and move to the next phase of our evolution,” Ulman wrote.

Despite the downturn, Livestrong last month agreed to give $50 million over 10 years to the University of Texas’ new medical school for a program emphasizing “patient-centered” cancer care.

Livestrong’s donations have fallen 63 percent from $41 million in 2009, the year Armstrong came out of retirement and finished third in the Tour de France. He won the race seven times, only to have those titles later stripped away after his doping admission.

Daniel Borochoff, founder of CharityWatch, which analyzes the work of approximately 600 charities, said the sharp decline last year was expected.

“It is a big hit,” Borochoff said. “Not to say they won’t be able to recover as time goes by. It’s fresh in people’s mind.”

Livestrong was particularly vulnerable to the scandal surrounding its founder because the popularity of both was so deeply connected. Armstrong’s doping revelations led big corporate sponsors and partners such as Nike and Dick’s Sporting Goods to flee by either canceling contracts or not renewing them. For corporations, the taint of doping was too strong to stay, and individual donors were angry, Borochoff said.

“People go through a mourning process when they hear of the scandal. They were a big supporter, he was a big hero and they were fans. Then you’re embarrassed and ashamed. It’s a lot of emotions,” Borochoff said. “Later, your rational facilities take over and realize the organization serves a worthy purpose, that it is not a man and can bring in new leadership.”

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE